weight-loss drugs
Unexpected Muscle Loss Linked to Popular Weight-Loss Drugs
Recent studies raise alarms about weight-loss drugs causing unexpected muscle loss.
Eli Lilly’s Market Share Declines as Novo Nordisk Maintains Position
Eli Lilly’s market share is declining in India due to generic weight-loss drugs, while Novo Nordisk maintains a stable position amidst competition.
Indian Drugmakers Launch Affordable Alternatives to Ozempic and Wegovy
Indian pharmaceutical companies are launching affordable alternatives to Novo Nordisk’s Ozempic and Wegovy, expanding access to weight-loss medications.
Pharmaceutical Stocks Surge as Ozempic Ingredient Patent Expires
Pharmaceutical stocks have surged up to 4% as Ozempic’s key ingredient patent expires, paving the way for generics and transforming obesity treatment.
Natco Introduces Semaglutide at Rs 1,290: A New Era for Diabetes Treatment
Natco Pharma launches semaglutide at Rs 1,290, aiming to make diabetes treatment more accessible and reshape the weight-loss drug market in India.
Ozempic Patent Expiry Sparks Weight-Loss Drug Surge in India
The expiry of Ozempic’s patent is set to revolutionize weight-loss drug availability in India, enabling more affordable options for patients.
Ozempic Patent Expiration Set to Ignite Weight-Loss Drug Market in India
The Ozempic patent expiration in 2026 will bring generics to India, reshaping the weight-loss drug market amid concerns of misuse.